全球静脉血栓栓塞治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

全球静脉血栓栓塞治疗市场的需求预计将从 2023 年的 127349 万美元达到 2032 年的近 280958 万美元，2024-2032 年研究期间复合年增长率为 9.19%。

静脉血栓栓塞（VTE）是一种在上肢和下肢深层静脉形成血栓，导致深部静脉血栓（DVT）的疾病。当这些血块到达肺部时，称为肺栓塞（PE）。它会导致其中一根肺动脉阻塞。 VTE 是一种诊断不足但严重的疾病，甚至可能导致死亡和残疾。 VTE 的可用治疗方案是溶栓疗法和抗凝血药物（可作为血液稀释剂）。静脉血栓栓塞也可以用某些机械装置来治疗，例如加压装置、血栓切除系统和过滤器。

市场动态

全球静脉血栓栓塞治疗市场成长的主要驱动力是静脉血栓栓塞发病率的增加和对现有治疗方案的认识的提高。新型 VTE 治疗设备的推出，增加患者的治疗选择数量将对 VTE 治疗市场做出重大贡献。此外，VTE治疗的技术进步，例如肝素和低分子量相关抑制剂的开发，预计将为VTE市场带来利润丰厚的成长机会。然而，与新上市药物和疗法的批准和采用以及与 VTE 药物相关的併发症相关的严格规则和法规可能会阻碍静脉血栓栓塞治疗市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球静脉血栓栓塞治疗市场的各个细分市场进行了包容性评估。静脉血栓栓塞治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

静脉血栓栓塞治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按设备

• 压缩系统
• 血栓切除系统
• 下腔静脉过滤器
• 丝袜
• 其他的

按申请

• 深层静脉栓塞
• 肺栓塞

按最终用途

• 医院
• 导尿实验室
• 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲静脉血栓栓塞治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。静脉血栓栓塞治疗市场的主要参与者包括波士顿科学公司、AngioDynamics、Cardinal Health、Covidien、Daesung Maref、Cook Medical、Argon Medical Products。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：静脉血栓栓塞治疗 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按设备分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球静脉血栓栓塞治疗市场分析：依设备分类

• 按设备概述
• 按设备进行历史和预测数据分析
• 压缩系统
• 血栓切除系统
• 下腔静脉过滤器
• 丝袜
• 其他的

第 6 章：全球静脉血栓栓塞治疗市场分析：依应用分类

• 概述：按应用
• 历史与预测资料分析：按应用分类
• 深层静脉栓塞
• 肺栓塞

第 7 章：全球静脉血栓栓塞治疗市场分析：依最终用途分类

• 按最终用途分类的概述
• 按最终用途分类的历史和预测资料分析
• 医院
• 导尿实验室
• 其他的

第 8 章：全球静脉血栓栓塞治疗市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区按国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲按国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：静脉血栓栓塞治疗公司的竞争格局

• 静脉血栓栓塞治疗市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Boston Scientific Corporation
• 公司概况
• 公司收入
• 产品
• 最新动态
• AngioDynamics
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cardinal Health
• 公司概况
• 公司收入
• 产品
• 最新动态
• Covidien
• 公司概况
• 公司收入
• 产品
• 最新动态
• Daesung Maref
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cook Medical
• 公司概况
• 公司收入
• 产品
• 最新动态
• Argon Medical Products
• 公司概况
• 公司收入
• 产品
• 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

The global demand for Venous Thromboembolism Treatment Market is presumed to reach the market size of nearly USD 2809.58 Million by 2032 from USD 1273.49 Million in 2023 with a CAGR of 9.19% under the study period 2024-2032.

Venous thromboembolism (VTE) is a medical condition where blood clot is formed in the deep veins of the upper and lower extremities, resulting in deep vein thrombosis (DVT). When these blood clots reach the lungs, it is known as pulmonary embolism (PE). It leads to blockage of one of the pulmonary arteries. VTE is an underdiagnosed but serious condition, to the extent that it can even cause death and disability. The available treatment options for VTE are thrombolytic therapy and anticoagulant drugs, acting as blood thinners. Venous thromboembolism can also be treated with certain mechanical devices, such as, compression devices, thrombectomy systems and filters.

MARKET DYNAMICS

The key drivers behind global venous thromboembolism treatment market growth are increasing incidence of VTE and increasing awareness about the existing treatment options. Introduction of new VTE treatment devices, increasing the number of treatment choices for patients will contribute significantly towards VTE treatment market. Furthermore, technological advancements in VTE treatment, such as, development of heparins and associated inhibitors with low molecular weight are expected to bring lucrative growth opportunities for VTE market. However, strict rules and regulations related to approval and adoption of newly launched drugs and therapies and complications associated with VTE drugs may hamper the growth of venous thromboembolism treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Venous Thromboembolism Treatment. The growth and trends of Venous Thromboembolism Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Venous Thromboembolism Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device

• Compression System
• Thrombectomy Systems
• IVC Filters
• Stockings
• Others

By Application

• Deep Vein Thrombosis
• Pulmonary Embolism

By End-use

• Hospitals
• Catheterization Laboratories
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Venous Thromboembolism Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Venous Thromboembolism Treatment market include Boston Scientific Corporation, AngioDynamics, Cardinal Health, Covidien, Daesung Maref, Cook Medical, Argon Medical Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. VENOUS THROMBOEMBOLISM TREATMENT - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Device
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY DEVICE

• 5.1. Overview By Device
• 5.2. Historical and Forecast Data Analysis By Device
• 5.3. Compression System Historic and Forecast Sales By Regions
• 5.4. Thrombectomy Systems Historic and Forecast Sales By Regions
• 5.5. IVCFilters Historic and Forecast Sales By Regions
• 5.6. Stockings Historic and Forecast Sales By Regions
• 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Deep Vein Thrombosis Historic and Forecast Sales By Regions
• 6.4. Pulmonary Embolism Historic and Forecast Sales By Regions

7. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data Analysis By End-use
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Catheterization Laboratories Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE VENOUS THROMBOEMBOLISM TREATMENT COMPANIES

• 9.1. Venous Thromboembolism Treatment Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Boston Scientific Corporation
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. AngioDynamics
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Cardinal Health
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Covidien
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Daesung Maref
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Cook Medical
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Argon Medical Products
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Device (USD MN)
• Compression System Market Sales By Geography (USD MN)
• Thrombectomy Systems Market Sales By Geography (USD MN)
• IVCFilters Market Sales By Geography (USD MN)
• Stockings Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Deep Vein Thrombosis Market Sales By Geography (USD MN)
• Pulmonary Embolism Market Sales By Geography (USD MN)
• Analysis By End-use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Catheterization Laboratories Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Venous Thromboembolism Treatment Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Venous Thromboembolism Treatment Report
• Market Research Process
• Market Research Methodology
• Global Venous Thromboembolism Treatment Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Device
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Device (USD MN)
• Compression System Market Sales By Geography (USD MN)
• Thrombectomy Systems Market Sales By Geography (USD MN)
• IVCFilters Market Sales By Geography (USD MN)
• Stockings Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Deep Vein Thrombosis Market Sales By Geography (USD MN)
• Pulmonary Embolism Market Sales By Geography (USD MN)
• Global Market Analysis By End-use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Catheterization Laboratories Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.